In today's session, these stocks are experiencing unusual volume.
By Mill Chart
Last update: Apr 30, 2024
Discover the stocks with unexpected trading volume in today's session on the US markets.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| INHD | 7.23% | The trading volume of INNO HOLDINGS INC (NASDAQ:INHD) today is 598.07K shares, which is considered unusual. The share price of NASDAQ:INHD increased by 7.23% today, reflecting positive market movement. This volume is 45.49% above the average 50 day volume. |
| CAUD | 1.62% | Today, COLLECTIVE AUDIENCE INC (NASDAQ:CAUD) stands out with a high volume of 4.34M shares. The share price of NASDAQ:CAUD increased by 1.62% today, reflecting positive market movement. The average daily volume over 50 days is 3.51M, so this is 23.62% above the average volume. |
| CYCC | 48.16% | CYCLACEL PHARMACEUTICALS INC's (NASDAQ:CYCC) traded a high volume of 18.88M shares. Investors in NASDAQ:CYCC are enjoying a price surge of 48.16% today, indicating bullish market sentiment. This volume is 13.0K% above the average 50 day volume. Earlier today the company had a press release: Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules. |
| MULN | 16.61% | Today, MULLEN AUTOMOTIVE INC (NASDAQ:MULN) stands out with a high volume of 41.89M shares. Investors in NASDAQ:MULN are enjoying a price surge of 16.61% today, indicating bullish market sentiment. Today's trading volume is 2.0K% above the average 50-day volume, indicating a significant deviation from the norm. A press release (California Issues HVIP Approval, Granting Mullen’s Class 3 EV Trucks a $45,000 Cash Voucher Per Vehicle Sold) was released yesterday. |
| DCPH | 0.14% | DECIPHERA PHARMACEUTICALS IN (NASDAQ:DCPH) has an unusual volume of 2.28M shares today. The market is favoring NASDAQ:DCPH today, as its share price records a notable increase of 0.14%. In comparison to the average daily volume of the last 50 days, the current volume is 51.48% above. This suggests a notable change in trading activity. NASDAQ:DCPH is releasing earnings today. Earlier today the company had a press release: ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals. |
| BMRA | 13.18% | So far 568.52K shares of BIOMERICA INC (NASDAQ:BMRA) have traded in today's session. The share price increased by 13.18%. With an average volume of 213.4K over the past 50 days, the current volume is 166.0% above the average. This deviation signals a potential shift in market dynamics. |
| POET | 6.46% | POET TECHNOLOGIES INC (NASDAQ:POET) has an unusual volume of 2.22M shares. NASDAQ:POET is showing a positive trend today, with a price increase of 6.46%. The current trading volume is 285.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. Yesterday the company had a press release: POET Announces Additional Private Placement Financing for CAD$10 Million. |
| ANVS | -16.9% | ANNOVIS BIO (NYSE:ANVS) has an unusual volume of 1.23M shares today. The share price decreased by 16.9%. This is 178.0% above the average daily volume of the last 50 days. A press release (Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease) was released yesterday. |
| HWH | 2.71% | With 2.77M shares traded so far, HWH INTERNATIONAL INC (NASDAQ:HWH) is experiencing an unusual level of activity today. The share price of NASDAQ:HWH increased by 2.71% today, reflecting positive market movement. Today's trading volume is 54.87% above the average 50-day volume, indicating a significant deviation from the norm. |
| ARQQ | -1.96% | 3.68M shares of ARQIT QUANTUM INC (NASDAQ:ARQQ) have been traded so far today. NASDAQ:ARQQ is experiencing a downward trend, with a decline of 1.96%. The average daily volume over the past 50 days is 1.75M. Hence, the current volume is 110.0% above the average volume, indicating a deviation from the usual trading pattern. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
ANNOVIS BIO
NYSE:ANVS (5/17/2024, 7:04:00 PM)
After market: 8.3 -0.01 (-0.12%)8.31
+0.28 (+3.49%)
ANVS News
19 hours ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
a day ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
2 days ago - Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
5 days ago - InvestorPlaceANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
5 days ago - Annovis Bio Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsMALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, provided updates from across the organization and announced first quarter financial results.
9 days ago - ChartmillWhat's going on in today's sessionTop movers analysis one hour before the close of the markets on 2024-05-09: top gainers and losers in today's session.
9 days ago - Annovis Bio Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseMALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
12 days ago - Annovis Bio Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersMALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
17 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.The trading volume of these stocks is deviating from the norm in today's session.
